Changes Mimicking New Leptomeningeal Disease After Intensity-Modulated Radiotherapy for Medulloblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 214-221

  Muscal, Jodi A ^a   Jones, Jeremy Y ^a   Paulino, Arnold C ^a,b   Bertuch, Alison A ^a   Su, Jack ^a   Woo, Shiao Y ^c   Mahoney Jr , Donald H ^a   Chintagumpala, Murali ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Intensity modulated radiotherapy; Magnetic resonance imaging; Medulloblastoma; Pediatrics; Surveillance

Indexed keywords

ATOMS; CHEMOTHERAPY; MAGNETIC MATERIALS; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; PEDIATRICS; PHYSICAL THERAPY; RADIOTHERAPY;

CHARACTERISTIC TIMES; CONTRAST ENHANCEMENTS; INTENSITY-MODULATED RADIOTHERAPY; LEPTOMENINGEAL DISEASES; MEDULLOBLASTOMA; MULTIFOCAL; NEUROIMAGING; NODULAR ENHANCEMENTS; POSTE-RIORS; RETROSPECTIVE REVIEWS; SIGNAL CHANGES; SURVEILLANCE; TRANSIENT CHANGES;

RESONANCE;

ADOLESCENT; ADULT; ARTICLE; BRAIN STEM; CEREBELLUM; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINX DISORDER; NEUROIMAGING; PARENCHYMA; PEDIATRICS; POSTERIOR FOSSA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; MENINGEAL NEOPLASMS; MENINGIOMA; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL;

EID: 57649112488     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.03.056     Document Type: Article

References (24)

1. Blaney S.M., Kun L.E., Hunter J., et al. Tumors of the central nervous system. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 5th ed. (2006), Lippincott Williams & Wilkins, Philadelphia, PA 818-825
2. Teh B.S., Woo S.Y., and Butler E.B. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. Oncologist 4 (1999) 433-442
3. Hertzberg H., Huk W.J., Ueberall M.A., et al., German Late Effects Working Group. CNS late effects after ALL therapy in childhood: Part I. Neurological findings in long-term survivors of childhood ALL-An evaluation of the interferences between morphology and neuropsychological performance. Med Pediatr Oncol 28 (1997) 387-400
4. Bakardjiev A.I., Barnes P.D., Goumnerova L.C., et al. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer 78 (1996) 864-873
5. Helton K.J., Edwards M., Steen G., et al. Neuroimaging-detected late transient treatment-induced lesions in pediatric patients with brain tumors. J Neurosurg 102 Suppl. 2 (2005) 179-186
6. Fouladi M., Chintagumpala M., Laningham F.H., et al. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 22 (2004) 4551-4560
7. Huang E., Teh B.S., Strother D.R., et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 52 (2002) 599-605
8. Packer R.J., Gajjar A., Vezina G., et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24 (2006) 4202-4208
9. Gajjar A., Chintagumpala M., Ashley D., et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 7 (2006) 813-820
10. Mahoney Jr. D.H., Strother D., Camitta B., et al. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: A pilot Pediatric Oncology Group study. J Clin Oncol 14 (1996) 382-388
11. Strother D., Ashley D., Kellie S.J., et al. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: Results of a collaborative study. J Clin Oncol 19 (2001) 2696-2704
12. Matsumoto K., Takahashi S., Sato A., et al. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy-An MR analysis. Int J Radiat Oncol Biol Phys 32 (1995) 913-918
13. Wilson D.A., Nitschke R., Bowman M.E., et al. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia. Radiology 180 (1991) 205-209
14. Mahoney Jr. D.H., Shuster J.J., Nitschke R., et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-A Pediatric Oncology Group study. J Clin Oncol 16 (1998) 1712-1722
15. Pääkö E., Vainionpää L., Lanning M., et al. White matter changes in children treated for acute lymphoblastic leukemia. Cancer 70 (1992) 2728-2733
16. Reddick W.E., Russell J.M., Glass J.O., et al. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging 18 (2000) 787-793
17. Dietrich U., Wanke I., Mueller T., et al. White matter disease in children treated for malignant brain tumors. Childs Nerv Syst 17 (2002) 731-738
18. Bouffet E., Doz F., Demaille M.C., et al. Improving survival in recurrent medulloblastoma: Earlier detection, better treatment or still an impasse?. Br J Cancer 77 (1998) 1321-1326
19. Ashley D.M., Meier L., Kerby T., et al. Response of recurrent medulloblastoma to low-dose oral etoposide. J Clin Oncol 14 (1996) 1922-1927
20. Crafts D.C., Levin V.A., Edwards M.S., et al. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. J Neurosurg 49 (1978) 589-592
21. Lefkowitz I.B., Packer R.J., Siegel K.R., et al. Results of the treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine and vincristine. Cancer 65 (1990) 412-417
22. Wara W.M., Le Q.T., Sneed P.K., et al. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 30 (1994) 551-556
23. Dunkel I.J., Boyett J.M., Yates A., et al., Children's Cancer Group. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 16 (1998) 222-228
24. Torres C.F., Rebsamen S., Silber J.H., et al. Surveillance scanning of children with medulloblastoma. N Engl J Med 330 (1994) 892-895